Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Dec;41(12):1690-1701.
doi: 10.1097/PAS.0000000000000944.

HPV-related Multiphenotypic Sinonasal Carcinoma: An Expanded Series of 49 Cases of the Tumor Formerly Known as HPV-related Carcinoma With Adenoid Cystic Carcinoma-like Features

Affiliations

HPV-related Multiphenotypic Sinonasal Carcinoma: An Expanded Series of 49 Cases of the Tumor Formerly Known as HPV-related Carcinoma With Adenoid Cystic Carcinoma-like Features

Justin A Bishop et al. Am J Surg Pathol. 2017 Dec.

Abstract

Human papillomavirus (HPV)-related multiphenotypic sinonasal carcinoma (HMSC), originally known as HPV-related carcinoma with adenoid cystic carcinoma-like features, is a peculiar neoplasm that is restricted to the sinonasal tract, exhibits features of both a surface-derived and salivary gland carcinoma (particularly adenoid cystic carcinoma), and is associated with high-risk HPV. Given the limited number of published cases, the full clinicopathologic spectrum of this neoplasm is unclear. Here, we present an updated experience of 49 cases. All cases of HMSC were obtained from the authors' files. Immunohistochemistry for p16, c-kit, and myoepithelial cell markers (S100, actin, calponin, p63, and/or p40) was performed along with RNA in situ hybridization for HPV (type 33-specific as well as a high-risk cocktail). Fluorescence in situ hybridization studies for fusions of MYB, NFIB, and MYBL1 was performed on a subset of cases. Clinical follow-up was obtained from medical records. A total of 49 cases of HMSC were collected. Twenty-eight (57%) were from women and 18 (43%) from men, ranging in age from 28 to 90 years (mean, 54 y). Of 40 cases with detailed staging information, 43% of HMSCs presented with a high T-stage (T3 or T4). Histologically, most grew predominantly as solid nests of basaloid cells exhibiting high mitotic rates and frequent necrosis, with histologic and immunohistochemical evidence of myoepithelial differentiation. Most cases also demonstrated foci of cribriform and/or tubular growth, along with an inconspicuous population of ducts. Thirty-four (69%) cases demonstrated an unusual pattern of surface involvement where markedly atypical squamous cells colonized tracts of the sinonasal mucosa. Less consistent histologic features included squamous differentiation within the invasive tumor (n=6), sarcomatoid transformation (n=5) including overt chondroid differentiation (n=3), and prominent epithelial-myoepithelial carcinoma-like growth (n=3). All cases were positive for p16 by immunostaining and HPV by RNA in situ hybridization. Thirty-three (67%) were positive for HPV 33. No cases tested for MYB, MYBL1, or NFIB gene fusions were positive. In the 38 cases with follow-up data, (mean follow-up, 42 mo) 14 recurred locally and 2 metastasized (lung, finger). There were no regional lymph node metastases, and no tumor-related deaths. HMSC is a distinct sinonasal neoplasm characterized by myoepithelial differentiation, frequent surface epithelial involvement, and the presence of high-risk HPV (especially type 33). Although it classically exhibits a cribriforming pattern that closely resembles adenoid cystic carcinoma, our expanded series highlights a histologic spectrum that is much broader than previously recognized, warranting a change in terminology. HMSC usually presents as a large and destructive sinonasal mass with high-grade histologic features, but it paradoxically behaves in a relatively indolent manner, underscoring the importance of distinguishing HMSC from true adenoid cystic carcinoma, squamous cell carcinoma, and other histologic mimickers.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Clinical and gross appearance of HPV-related multiphenotypic sinonasal carcinoma.
Figure 2
Figure 2
Most HPV-related multiphenotypic sinonasal carcinomas demonstrated a predominantly solid growth pattern (A), sometimes with an inverted growth pattern and fibrovascular cores (B). A cribriform growth pattern was commonly seen, imparting a highly adenoid cystic-like appearance (C). A focal tubular growth pattern was also seen in some cases (D).
Figure 3
Figure 3
Most HPV-related multiphenotypic sinonasal carcinomas were biphasic, with subtle eosinophilic ducts scattered among more prominent basaloid cells (A, B).
Figure 4
Figure 4
The basaloid cells of HPV-related multiphenotypic sinonasal carcinoma variably demonstrated histologic evidence of myoepithelial differentiation in the form of cell spindling (A), clear cell change (B), plasmacytoid morphology (C), and extracellular hyaline matrix deposition (D).
Figure 5
Figure 5
The variable histologic appearances of the tumor involvement of the surface epithelium seen in HPV-related multiphenotypic sinonasal carcinomas (A-F). It is not clear whether this finding is a truly premalignant (dysplastic) process.
Figure 6
Figure 6
The histologic spectrum of HPV-related multiphenotypic sinonasal carcinoma includes the presence of scattered anaplastic giant cells (A), squamous differentiation within the invasive tumor (B), an epithelial-myoepithelial carcinoma-like appearance (C) and sarcomatoid differentiation including heterologous cartilage formation (D).
Figure 7
Figure 7
HPV-related multiphenotypic sinonasal carcinomas were consistently positive for pancytokeratin, usually in a biphasic pattern with dark staining in ducts and lighter staining in the basaloid cells (A). Immunostaining for myoepithelial markers p40 (B) and calponin (C) tended to be in an abluminal pattern, staining ducts, while the staining distribution was more variable for S100, including a diffuse pattern (D).
Figure 8
Figure 8
The HPV-related multiphenotypic sinonasal carcinomas (A and D) were diffusely positive for p16 by immunohistochemistry (B and E) and high-risk HPV by RNA in situ hybridization (C and F) in both the surface and invasive components (A-C) and in both the ductal and abluminal tumor cells (D-F). The pattern of in situ hybridization signals was both punctate and diffuse (C and F), with the diffuse signals localizing to the tumor giant cells (C).

References

    1. Gillison ML, Koch WM, Capone RB, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. Journal of the National Cancer Institute. 2000;92:709–720. - PubMed
    1. Singhi AD, Westra WH. Comparison of human papillomavirus in situ hybridization and p16 immunohistochemistry in the detection of human papillomavirus-associated head and neck cancer based on a prospective clinical experience. Cancer. 2010;116:2166–2173. - PubMed
    1. El-Mofty SK, Lu DW. Prevalence of high-risk human papillomavirus DNA in nonkeratinizing (cylindrical cell) carcinoma of the sinonasal tract: a distinct clinicopathologic and molecular disease entity. Am J Surg Pathol. 2005;29:1367–1372. - PubMed
    1. Bishop JA, Guo TW, Smith DF, et al. Human papillomavirus-related carcinomas of the sinonasal tract. Am J Surg Pathol. 2013;37:185–192. - PMC - PubMed
    1. Alos L, Moyano S, Nadal A, et al. Human papillomaviruses are identified in a subgroup of sinonasal squamous cell carcinomas with favorable outcome. Cancer. 2009;115:2701–2709. - PubMed

MeSH terms